109 related articles for article (PubMed ID: 11270916)
1. Changes in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine or amitriptyline.
Zaninelli R; Bauer M; Jobert M; Müller-Oerlinghausen B
J Clin Psychopharmacol; 2001 Apr; 21(2):190-8. PubMed ID: 11270916
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study.
Bauer M; Zaninelli R; Müller-Oerlinghausen B; Meister W
J Clin Psychopharmacol; 1999 Apr; 19(2):164-71. PubMed ID: 10211918
[TBL] [Abstract][Full Text] [Related]
3. Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: a reanalysis of a randomized, double-blind study.
Pilhatsch M; Wolf R; Winter C; Lewitzka U; Bauer M
J Affect Disord; 2010 Nov; 126(3):453-7. PubMed ID: 20547424
[TBL] [Abstract][Full Text] [Related]
4. How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression.
Bschor T; Berghöfer A; Ströhle A; Kunz D; Adli M; Müller-Oerlinghausen B; Bauer M
J Clin Psychopharmacol; 2002 Aug; 22(4):427-30. PubMed ID: 12172345
[TBL] [Abstract][Full Text] [Related]
5. Serotonin syndrome after lithium add-on medication to paroxetine.
Sobanski T; Bagli M; Laux G; Rao ML
Pharmacopsychiatry; 1997 May; 30(3):106-7. PubMed ID: 9211572
[TBL] [Abstract][Full Text] [Related]
6. Comparative Efficacy of Newer Antidepressants in Combination with Pregabalin for Fibromyalgia Syndrome: A Controlled, Randomized Study.
Ramzy EA
Pain Pract; 2017 Jan; 17(1):32-40. PubMed ID: 26892006
[TBL] [Abstract][Full Text] [Related]
7. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
8. A double-blind study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives.
Bocchetta A; Bernardi F; Burrai C; Pedditzi M; Del Zompo M
Acta Psychiatr Scand; 1993 Dec; 88(6):434-9. PubMed ID: 8310852
[TBL] [Abstract][Full Text] [Related]
9. Treatment with paroxetine, but not amitriptyline, lowers levels of lipoprotein(a) in patients with major depression.
Paslakis G; Kopf D; Westphal S; Gilles M; Lederbogen F; Hamann B; Heuser I; Deuschle M
J Psychopharmacol; 2011 Oct; 25(10):1344-6. PubMed ID: 20952454
[TBL] [Abstract][Full Text] [Related]
10. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study.
Bird H; Broggini M
J Rheumatol; 2000 Dec; 27(12):2791-7. PubMed ID: 11128665
[TBL] [Abstract][Full Text] [Related]
11. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
Möslinger-Gehmayr R; Zaninelli R; Contu A; Oberhoff C; Gutschow K; Schindler AE; Staab HJ
Zentralbl Gynakol; 2000; 122(4):195-202. PubMed ID: 10795116
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
[TBL] [Abstract][Full Text] [Related]
13. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.
Ivković M; Damjanović A; Jovanović A; Cvetić T; Jasović-Gasić M
Psychiatr Danub; 2009 Jun; 21(2):187-93. PubMed ID: 19556947
[TBL] [Abstract][Full Text] [Related]
14. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
Alevizos B; Alevizos E; Leonardou A; Zervas I
Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
[TBL] [Abstract][Full Text] [Related]
16. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
Fava M; Alpert J; Nierenberg A; Lagomasino I; Sonawalla S; Tedlow J; Worthington J; Baer L; Rosenbaum JF
J Clin Psychopharmacol; 2002 Aug; 22(4):379-87. PubMed ID: 12172337
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
18. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
Greist J; McNamara RK; Mallinckrodt CH; Rayamajhi JN; Raskin J
Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
[TBL] [Abstract][Full Text] [Related]
19. Economic appraisal of citalopram in the management of single-episode depression.
Sclar DA; Skaer TL; Robison LM; Galin RS
J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):47S-54S. PubMed ID: 10507508
[TBL] [Abstract][Full Text] [Related]
20. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
